GRM5 and fragile X syndrome: mGluR5 may act as a master switch between the balance of catabolic and anabolic processes in nervous system development, maintained in part by regulating levels of APP metabolites, We have found increased plasma levels of APP and sAPPa in FXS vs. control subjects.